Semaglutide: A GLP-1 receptor agonist designed to regulate blood sugar, control appetite, and support weight loss. It mimics the natural GLP-1 hormone in your body, making it easier to feel full and consume less.
Tirzepatide: A dual-action medication targeting both GLP-1 and GIP (another key hormone in metabolism). This dual effect can lead to enhanced fat loss and better blood sugar control, often making it more effective for weight loss compared to Semaglutide.
Key Difference: Tirzepatide’s dual-action mechanism gives it a slight edge for those looking for faster results or greater metabolic support, while Semaglutide remains a highly effective, trusted option for sustainable weight loss.